CIK 0001746466
- Non-accelerated filer
- Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821554746
- Phone
- +1 858-412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 4,444 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 10,065 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Sr. Vice President and COO acquired 9,033 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 7,000 shares at $2.83 ($19,810)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $2.52 ($12,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $3.18 ($25,440)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 5,585 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 1,290 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $5.08 ($25,402)
- 4 Open-market sale Sr. Vice President and COO sold 11,434 shares at $5.49 ($62,715)
Page 5 of 9 · 177 filings